Concepedia

Author

Natasha M. Savage

Augusta UniversityORCID

Also Known As

N M Savage, N Savage, N. M. Savage, N. Savage, Natasha M Savage, Natasha M. Savage, Natasha Marie Savage, Natasha Savage

141

Publications

2.1K

Citations

23

H-Index

62

Concepts

All Affiliations

Augusta UniversityAugusta University HealthCharlie Norwood VA Medical CenterNational Cancer Center of GeorgiaStanford University
NM

About

Natasha M. Savage is an author at Augusta University specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

13

392

2

Health Sciences

5

5

113

3

Biostatistics

2

2

22

4

Engineering

1

1

12

5

Allergy

1

1

11

Natasha M. Savage

×

36

Publications

1.8K

Citations

21

H-Index

YearCitations

The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion

Chunwan Lu, Amy V. Paschall, Huidong Shi,

JNCI Journal of the National Cancer Institute

2016

282

The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells

Chunwan Lu, Priscilla S. Redd, Jeffrey R. Lee,

OncoImmunology

2016

215

JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer

Chunwan Lu, Asif Talukder, Natasha M. Savage,

OncoImmunology

2017

165

Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis

Mohammed L. Ibrahim, John D. Klement, Chunwan Lu,

Cell Reports

2018

122

Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR

Huabin Zhu, Brinda Bhatt, Sathish Sivaprakasam,

Nature Communications

2019

111

Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment

John D. Klement, Priscilla S. Redd, Chunwan Lu,

Cancer Cell

2023

111

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study

Heesun J. Rogers, J. W. Vardiman, John Anastasi,

Haematologica

2014

81

Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V

Celalettin Üstün, Christopher L. Corless, Natasha M. Savage,

Leukemia Research

2008

72

SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion

Chunwan Lu, Dafeng Yang, John D. Klement,

Cancer Immunology Research

2019

63

Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms

Nikhil Sahajpal, Ashis K. Mondal, Tatiana Tvrdik,

Journal of Molecular Diagnostics

2022

56

Page 1